Refractory B-Cell Prolymphocytic Leukemia

specific

3

Centers

1

Active Trials

Cancer Funding

Top Centers for Refractory B-Cell Prolymphocytic Leukemia(3)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
181.7
2
NCI Comprehensive
59.2
3
NCI Comprehensive
59.2

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →